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Aims We tested the hypothesis that, in heart failure with normal ejection fraction (HFNEF), diastolic dysfunction is accen-
tuated at increasing heart rates, and this contributes to impaired frequency-dependent augmentation of cardiac
output.
Methods
and results
In 17 patients with HFNEF (median age 69 years, 13 female) and seven age-matched control patients, systolic and
diastolic function was analysed by pressure–volume loops at baseline heart rate and during atrial pacing to 100
and 120 min
21. At baseline, relaxation was prolonged and end-diastolic left ventricular stiffness was higher in
HFNEF, whereas all parameters of systolic function were not different from control patients. This resulted
in smaller end-diastolic volumes, higher end-diastolic pressure, and a lower stroke volume and cardiac index in
HFNEF vs. control patients. During pacing, frequency-dependent upregulation of contractility indices (þdP/dtmax
and Ees) occurred similarly in HFNEF and control patients, but frequency-dependent acceleration of relaxation
(dP/dtmin) was blunted in HFNEF. In HFNEF, end-diastolic volume and stroke volume decreased with higher heart
rates while both remained unchanged in control patients.
Conclusion In HFNEF, frequency-dependent upregulation of cardiac output is blunted. This results from progressive volume
unloading of the left ventricle due to limited relaxation reserve in combination with increased LV passive stiffness,
despite preserved force–frequency relation.
-----------------------------------------------------------------------------------------------------------------------------------------------------------
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Introduction
Nearly, half of patients presenting with heart failure have normal
ejection fraction (HFNEF).
1,2 Recent data show that the mortality
of patients with HFNEF is comparable to patients with systolic
heart failure (SHF).
1,2 In addition, it has been speculated that
HFNEF and SHF are different stages of the same disease.
3
Moreover, mostly men and relatively young patients have been
studied in the few available invasive studies,
4–6 whereas the
majority of patients with HFNEF in epidemiological studies are
elderly females.
1
A characteristic feature of SHF is an altered force–frequency
relation with blunted frequency potentiation of contractility result-
ing in the absence of frequency-dependent upregulation of cardiac
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7 Little is known thus far about the impact of atrial pacing
and the force–frequency relation in patients with HFNEF.
Accordingly, the present study was performed to test the
hypothesis that in HFNEF frequency-dependent upregulation of
cardiac function is blunted through mechanisms different from
those which have been described in SHF. We specially focused
on a cohort of HFNEF patients that resembles the typical age
and gender characteristics observed in large-scale, epidemiological
studies.
Methods
Patient recruitment
Patients with suspected diastolic heart failure
Between January 2005 and April 2008, patients suffering from symp-
toms of heart failure undergoing cardiac catherization at the Depart-
ment of Cardiology and Pneumology at the University of Go ¨ttingen
were screened for eligibility to this study. If other reasons for dyspnoea
[e.g. abnormal pulmonary function on spirometry, valvular disease
greater ﬁrst degree, impaired systolic function (ejection fraction
,50%)] were excluded, diastolic heart failure was suspected and
patients were offered to undergo an invasive study to conﬁrm the diag-
nosis of diastolic heart failure. Of note, the presence or absence of
diastolic dysfunction by echocardiography was not an inclusion criteria.
A total of 19 patients were studied.
One patient had hypertrophic obstructive cardiomyopathy and was
excluded from further analysis. Signiﬁcant coronary artery disease (ste-
nosis .50%) was excluded in all but one patient. In this one patient
who complained of angina and dyspnoea on exertion, angioplasty of
the circumﬂex artery resolved the angina, but the dyspnoea remained
and therefore pressure–volume loop analysis was performed in a
second procedure.
Therefore, 18 patients were analysed for this study, and all but one
patient (n ¼ 17) fulﬁlled the recent criteria for the invasive diagnosis of
diastolic heart failure.
8 All patients were extensively informed about
the procedure and all potential complications and gave written
informed consent.
Control patients
Six patients who were referred to the Department of Cardiology and
Pneumology of the Charite ´ Campus Benjamin Franklin in Berlin
because of atypical chest pain served as controls. Data on some of
the control patients have been published previously.
4 In addition,
one patient in Go ¨ttingen, in whom diastolic heart failure was invasively
excluded, was also part of the control group. Signiﬁcant coronary
artery disease was excluded in all of the control patients.
Invasive haemodynamic assessment by conductance
technique
The conductance procedure has previously been described in detail.
4
In brief, the seven French conductance catheter (CD Leycom, Zoe-
termeer, The Netherlands) was placed into the left ventricle. This
catheter contains seven segments, each segment provides a separate
conductance signal and a pressure sensor. After calibration including
analysis of the conductance of the blood (rho), analysis of the so-called
slope factor a (calibration by thermodilution) and parallel conductance
(Vc) of the surrounding tissue (e.g. myocardium, pericardium) by tran-
sient infusion of hypertonic saline solution (10%), this conductance
signal can be transverted into a volume signal. The total LV volume
signal was then calculated from only those segments that were comple-
tely placed within the left ventricle.
To assess pressure–volume relationships, preload was reduced by
use of a vena cava occlusion balloon that was placed in the right
atrium and drawn back into the inferior vena cava to acutely lower
venous return at each heart rate to obtain left ventricular elastance
(Ees) and left ventricular stiffness constant b. Analysis of the
pressure–volume loops was performed with custom software as
described previously,
9 t was determined by the Glantz method.
10
Relaxation time (Trelax) was deﬁned as the time from dP/dtmin to
minimal left ventricular pressure and relaxation was considered incom-
plete, if the ratio of Trelax to t was less than 3.5.
5,11 Pacing was per-
formed by a temporal pacing lead in the right atrium.
Spiroergometry
Spiroergometry was performed by standard technique on a bicycle
ergometer (ZAN 600, nSpire Health GmbH, Oberthulba, Germany).
Symptom-limited cardiopulmonary exercise testing on a bicycle erg-
ometer started at a workload of 20 W with a stepwise 20 W incre-
ment every 2 min. Peak VO2 was deﬁned as the maximum value of
the last three 10 s averages.
Echocardiography
Echocardiographic assessment was performed as previously
described,
12 according to the Guidelines of the American Society of
Echocardiography.
13 Left ventricular mass was estimated by the Dever-
eux formula.
14 Left ventricular mass index (LVMI) was deﬁned as the
ratio of left ventricular mass to body surface area. Left ventricular
hypertrophy was deﬁned as a LVMI . 95 g/m
2 in women and a
LVMI . 115 g/m
2 in men. For the determination of the E/Ea ratio,
the mean of septal and lateral mitral annulus tissue velocities
8 was
used. Diastolic dysfunction was classiﬁed in accordance with a large
epidemiological study.
15
Laboratory measurements
N-terminal pro brain natriuretic peptide (NT-proBNP) was analysed
by a commercially available ELISA (Elecsys, Roche Diagnostics).
Statistics
Data were analysed using SPSS 15.0 software (SPSS, Chicago, IL, USA)
and by SigmaStat 3.5 (Systat Software, Erkrath, Germany). Unless
stated otherwise, metric data are expressed as median (25th–75th
percentile). Differences between groups of patients were assessed
by a Mann–Whitney U test (for unpaired metric data) or x
2 test
(for categorical data). For the analysis of pacing effects, an ANOVA
for repeated measurements was used with a Tukey’s post hoc test. If
the compound symmetry assumption was not fulﬁlled, a Green-
house–Geisser correction was used. A two-tailed P , 0.05 was
deﬁned as statistical signiﬁcant.
The authors had full access to and take full responsibility for the
integrity of the data. All authors have read the manuscript and agree
to it as written.
Results
Patient characteristics
Table 1 shows baseline characteristics of the patients with HFNEF
and the control patients. HFNEF and controls were of similar age,
but more patients in the HFNEF group were female. Furthermore,
HFNEF patients had more often hypertension and were more
R. Wachter et al. 3028obese than controls. All HFNEF patients had NYHA II or III heart
failure symptoms and signiﬁcantly higher NT-proBNP values when
compared with controls. Exercise capacity as assessed by spiroer-
gometry was largely reduced in HFNEF patients. Patients with
HFNEF showed typical echocardiographic signs of left ventricular
hypertrophy (increased left ventricular wall diameters and LVMI),
diastolic dysfunction and left atrial enlargement (decreased E/A
ratio, increased E/Ea ratio, dilated left atrium). Left ventricular
hypertrophy was present in 13 patients with HFNEF and in one
of the control patients (P ¼ 0.005). At Doppler echocardiography,
two patients in the HFNEF group had ﬁrst-degree diastolic dys-
function, the other 15 had second-degree diastolic dysfunction.
Invasive haemodynamic data
Figure 1 shows typical pressure–volume loop recordings in a
patient with normal diastolic function (left panel) and in a
HFNEF patient. In HFNEF, the diastolic pressure–volume relation
(red line) was shifted upwards and to the left, so the left ventricle
in these patients is operating with higher pressures at smaller
volumes near end-diastole.
Table 2 summarizes haemodynamic parameters at baseline.
Indices of systolic function did not differ between HFNEF patients
and controls. End-diastolic volume and end-diastolic volume index
were reduced and end-diastolic pressure increased in HFNEF;
HFNEF patients had impaired active relaxation and passive diastolic
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Table 1 Baseline characteristics
HFNEF (n 5 17) Controls (n 5 7) P-value
Demographic data
Age (years) 69 (63–74) 65 (62–68) 0.226
Female/male (n) 13/4 2/5 0.028
Body mass index (kg/m
2) 29.4 (26.8–32.3) 26.3 (24.8–26.6) 0.016
Hypertension (%) 94.1 57.1 0.027
Diabetes (%) 11.8 14.3 0.865
CAD (%) 5.9 0 0.512
Symptoms
NYHA II (%) 52.9 0 ,0.001
NYHA III (%) 47.1 0 ,0.001
NT-proBNP (pg/mL) 254 (128.5–499.8) 41.5 (22–55) 0.001
Medication
ACE-inhibition/AT1-antagonist (%) 76.5 42.9 0.112
Beta-blockers (%) 70.6 28.6 0.058
Calcium channel blockers (%) 41.2 14.3 0.204
Diuretics (%) 70.6 14.3 0.012
Echocardiography
IVS (mm) 12.0 (11.0–14.0) 10.0 (8.0–10.0) 0.001
LVPW (mm) 11.0 (10.0–12.0) 10.0 (8.0–11.0) 0.075
LVEDD (mm) 49.0 (47.0–50.8) 47.0 (46–49) 0.383
Left atrial diameter (mm) 43 (41–48) 38 (35–40) 0.011
LVMI (g/m
2) 120 (104–140) 83 (67–94) 0.008
E/A ratio 0.95 (0.86–1.20) 1.23 (1.05–1.65) 0.055
EDCT (ms) 253 (191–303) 177 (160–190) 0.011
IVRT (ms) 85 (73–107) 91 (86–92) 0.783
E/Ea (septal) ratio 13.9 (10.0–22.5) 7.7 (6.5–9.6) 0.005
E/Ea (lateral) ratio 11.5 (8.0–16.0) 6.8 (4.7–7.9) 0.001
Spiroergometry (only in HFNEF)
Maximal performance (W) 80 (70–100)
Peak VO2 (mL/kg/min) 12.5 (10.4–15.0)
VE/VCO2 slope 33.5 (30.2–38.9)
CAD, coronary artery disease; NYHA, New York Heart Association; ACE, angiotensin converting enzyme; AT, angiotensin; IVS, interventricular septum diameter; LVPW, left
ventricular posterior wall diameter; LVEDD, left ventricular enddiastolic diameter; LVMI, left ventricular mass index; E, transmitral early left ventricular diastolic ﬁlling velocity;
A, transmitral late left ventricular diastolic ﬁlling velocity; EDCT, E deceleration time; IVRT, isovolumetric relaxation time; Ea, mitral annular early diastolic tissue Doppler velocity;
VO2, oxygen uptake; VE, ventilatory exchange; VCO2, carbon dioxide output.
Relaxation in diastolic heart failure 3029function parameters. The left ventricular stiffness constant b [an
estimate of the passive elastic properties (distensibility) of the ven-
tricle
16] was signiﬁcantly higher in HFNEF (0.0245) when com-
pared with controls (0.0107, P , 0.001) with no overlap
between groups (Figure 2).
Haemodynamic effects of temporal
atrial pacing
Temporal atrial pacing was performed at rates of 100 and
120 b.p.m. Parameters of systolic function at baseline and with
pacing are shown in Figure 3 and Table 3. There was a comparable
signiﬁcant increase in dP/dtmax in HFNEF and control patients, indi-
cating a preserved frequency potentiation of contractility in
HFNEF. End-systolic elastance (Ees) increased with pacing in the
HFNEF patients, but not in the control patients. End-systolic
volume at 100 mmHg (ESV100mmHg) did not change in both
groups with pacing, but was smaller in HFNEF at any heart rate.
Parameters of diastolic function and their change with pacing are
shown in Figure 4 and Table 3. With pacing, active relaxation (t,d P/
dtmin) became faster in both groups, however, even with the
highest heart rate, relaxation parameters were still abnormal in
the HFNEF group and different between HFNEF and control.
The results were similar in the groups with and without
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Table 2 Haemodynamic data at baseline heart rate
HFNEF (n 5 17) Controls (n 5 7) P-value
Systolic function
End-systolic pressure (mmHg) 133 (114–164) 118 (111–130) 0.172
End-systolic volume (mL) 27 (24–41) 64 (30–74) 0.181
End-systolic volume index (mL/m
2) 21 (13–24) 35 (18–38) 0.054
Ejection fraction (%) 71 (63–76) 66 (63–81) 0.974
End-systolic elastance (Ees) (mmHg/mL) 1.79 (1.19–3.04) 1.40 (1.26–1.65) 0.312
dP/dtmax (mmHg/s) 1444 (1244–1748) 1562 (1549–1866) 0.153
Diastolic function
End-diastolic pressure (mmHg) 16.8 (13.1–20.2) 6.3 (4.9–8.6) ,0.001
End-diastolic volume (mL) 108 (92–127) 158 (114–182) 0.019
End-diastolic volume index (mL/m
2) 61 (51–68) 76 (72–91) 0.009
t (ms) 55.3 (49.8–63.8) 41.8 (36.3–42.6) ,0.001
dP/dtmin (mmHg/s) 21643 (21924–21364) 21857 (22084–21577) 0.325
Stiffness constant b 0.0245 (0.0203–0.0315) 0.0107 (0.0089–0.0120) ,0.001
Global cardiac function
Heart rate (b.p.m.) 66 (60–68) 72 (67–90) 0.114
Cardiac index (mL/min/m
2) 2812 (2570–2997) 3980 (3066–4638) 0.007
Stroke volume index (mL/m
2) 44 (38–46) 61 (43–63) 0.061
Figure 1 Typical pressure volume loops during transient preload reduction by vena cava occlusion balloon. Left: 49-year-old female with
normal left ventricular function (control). Right: 64-year-old female patient with HFNEF. The red line indicates the end-diastolic pressure–
volume relation. The pressure–volume relation was shifted upwards and to the left in the HFNEF patient.
R. Wachter et al. 3030beta-blocker therapy. The stiffness constant b as a parameter of
passive diastolic properties did not change in either group, but b
was  2.5 times higher in HFNEF patients at all frequencies.
Relaxation was considered incomplete according to our deﬁ-
nition (Trelax , 3.5t) and was prominent in the HFNEF group,
while it was complete in nearly all controls. These data and data
on relaxation time and time in systole/diastole are shown in
Table 4. With pacing, the systolic and diastolic time intervals
were similarly reduced in both groups, and the ratio of systole/dia-
stole increased with pacing in both groups. Relaxation became
more incomplete with pacing in the HFNEF group, which was
due to a largely shortened relaxation time while t decreased
only slightly. In the controls, relaxation time and t decreased simi-
larly, and Trelax/t remained unchanged.
Figure 5 shows the changes in cardiac index, stroke volume
index, and left ventricular end-diastolic volume with pacing.
Control patients maintained stroke volume and end-diastolic
volume at higher heart rates, which led to an increase in cardiac
output. In HFNEF, stroke volume and end-diastolic volume
decreased and the decrease in stroke volume outbalanced the
increase in heart rate, leading to only a slight increase in cardiac
output at 100 b.p.m. and no further increase at 120 b.p.m.
Discussion
The present study shows that frequency-dependent upregulation
of cardiac output is blunted in HFNEF similar to recent obser-
vations in SHF. However, underlying mechanisms are completely
different, because in HFNEF,
(i) Frequency-dependent upregulation of contractility par-
ameters is preserved, despite a decrease in preload;
(ii) Frequency-dependent upregulation of relaxation parameters
is signiﬁcantly blunted;
(iii) A progressive decrease of end-diastolic volume at higher
heart rates results in reduction of stroke volume and blunting
of frequency-dependent upregulation of cardiac output.
This study indicates that mechanisms of dysfunction at least
regarding frequency-dependent regulation of cardiac performance
are different in SHF and HFNEF. The absolute value of dP/dtmax and
its increase with pacing is comparable to normal control patients in
our study as well as to control patients in other studies.
7 Also, end-
systolic elastance is higher and ESV100mmHg is smaller, indicating a
rather increased contractility in HFNEF. From these ﬁndings, we
conclude that HFNEF patients do not have clinically signiﬁcant sys-
tolic dysfunction as cause of their symptoms. Preserved systolic
function in HFNEF was previously described by others.
4–6
In contrast to virtually no difference in global systolic function, we
could clearly demonstrate abnormal relaxation and compliance in
HFNEF patients when compared with controls at baseline. At
resting heart rates, Tau was prolonged, and dP/dtmin tended to be
lower in HFNEF. With pacing, dP/dtmin and Tau signiﬁcantly declined
in controls, compatible with a frequency-dependent upregulation of
relaxation processes. In contrast, dP/dtmin did not decline with
higher heart rates in HFNEF and was signiﬁcantly slower at
120 b.p.m. when compared with controls; Tau declined also in
HFNEF with higher pacing rates, but its absolute value remained sig-
niﬁcantly higher than in controls and above the normal value of
48 ms at each pacing rate. These data indicate that HFNEF patients
show an impaired relaxation–frequency relation. We also demon-
strate alterations in the passive properties of the left ventricle, e.g.
in ventricular stiffness in HFNEF, which agree with previously pub-
lished data in younger male patients by Zile et al.
5
However,allofthesepatientswereasymptomaticduringrest,but
experiencedsymptomsonlyduringphysicalactivity.Areducedexer-
cisecapacitycanbeeasilyexplainedonthebasisofabluntedincrease
in cardiac output at higher heart rates in HFNEF, but dyspnoea is
more difﬁcult to explain from our data. While the subjective symp-
toms of dyspnoea may result from multifactorial causes, impaired
ventricular diastolic ﬁlling resulting in pulmonary congestion is a
commonly used explanation. We could clearly demonstrate a
heart rate dependent potentiation of relaxation abnormalities in
HFNEF, but left ventricular end-diastolic pressure (LVEDP)
decreased in our patients at higher pacing rates. While this obser-
vation is understandable from a haemodynamic point of view
(reduced volume ﬁlling will result in reduced ﬁlling pressure at the
end of diastole), it may not adequately reﬂect the situation under
more physiological conditions. In fact, in a recent study,
4 handgrip
exercise was associated with an increase in LVEDP in HFNEF
patients. In summary, impairedﬁlling ofthe ventricleduring exercise
may result in reduced cardiac output and increased pulmonary con-
gestion, and these pathologies will be accelerated at higher heart
rates in these patients.
Epidemiological studies suggest that the majority of patients with
HFNEF are women of older age.
1,15,17,18 Comparing these
characteristics to other invasive studies in HFNEF, patients in
former invasive studies were much younger (between 58 and 66
years
4–6) and the percentage of women was relatively low in most
Figure 2 Left ventricular stiffness constant b in control
patients and in patients with HFNEF. Stiffness was higher in all
the HFNEF patients with no overlap to controls.
Relaxation in diastolic heart failure 3031Figure 3 Parameters of contractility (dP/dtmax, end-systolic elastance and end-systolic volume at 100 mmHg) at baseline and with pacing at
100 and 120 b.p.m. (mean, SEM). Data are shown in red for the HFNEF and in blue for the control patients. Results of the multiple measure-
ments ANOVA are shown above the horizontal arrow (for the effects of beats per minute and interaction) and on the right side of the ﬁgure
(for comparison between HFNEF and controls).
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Table 3 Haemodynamic indices at 100 and 120 b.p.m.
HFNEF (n 5 17) Controls (n 5 7)
100/min 120/min 100/min 120/min
Systolic function
End-systolic pressure (mmHg) 134 (113–152) 119 (109–136)
† 121 (106–124) 128 (101–145)
Ejection fraction (%) 62 (58–76) 66 (54–73) 73 (68–77) 67 (66–78)
Diastolic function
End-diastolic pressure (mmHg) 7.6 (6.0–16.7)*
‡ 8.3 (5.6–17.7)*
‡ 4.6 (3.6–6.0) 4.5 (4.0–6.0)
*P , 0.05 vs. baseline.
†P , 0.05 vs. 100/min.
‡P , 0.05 vs. control.
R. Wachter et al. 3032Figure 4 Parameters of active relaxation (dP/dtmin, t) and passive stiffness (stiffness constant b) at baseline and with pacing at 100 and
120 b.p.m. (mean, SEM). Data are shown in red for the HFNEF and in blue for the control patients. Results of the multiple measurements
ANOVA are shown above the horizontal arrow (for the effects of beats per minute and interaction) and on the right side of the ﬁgure
(for comparison between HFNEF and controls).
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Table 4 Time in systole, diastole, and relaxation time in HFNEF patients
HFNEF (n 5 17) Controls (n 5 7)
Basal 100/min 120/min Basal 100/min 120/min
Tsys (ms) 420 (385–453)
‡ 343 (332–370)* 312 (297–336)*
†‡ 354 (332–374) 332 (308–334)* 299 (261–313)*
†
Tdiast (ms) 508 (450–568)
‡ 246 (230–264)* 193 (180–206)*
†‡ 476 (362–515) 265 (243–293)* 191 (184–227)*
†
Tsys (%) 45.7 (43.1–46.8) 58.4 (56.0–61.4)* 62.6 (59.1–63.8)*
† 42.7 (40.5–48.2) S.7 (51.1–58.1)* 61.5 (53.5–63.4)*
†
Trelax (ms) 166 (146–190) 153 (143–165)* 120 (74–145)*
† 152 (122–161) 136 (110–142) 118 (112–135)
t (ms) 55 (50–64)
‡ 50 (45–66)
‡ 51 (45–55)*
‡ 42 (36–43) 38 (36–40)* 34 (31–36)*
†
Trelax/t 3.08 (2.48–3.40) 2.98 (2.14–3.36)
‡ 2.00 (1.57–3.00)*
†‡ 3.63 (3.30–4.21) 3.71 (2.89–4.03) 3.53 (3.29–4.12)
Tsys, time in systole; Tdiast, time in diastole; Tsys (%), relative portion of systole; Trelax, relaxation time; Trelax/t, ratio relaxation time to t (isovolumetric time constant of relaxation).
*P , 0.05 vs. basal.
†P , 0.05 vs. 100/min.
‡P , 0.05 vs. controls.
Relaxation in diastolic heart failure 3033of these studies. Moreover, 88% of our patients had moderate or
severe diastolic dysfunction, consistent with epidemiological data.
15
This underscores that we have, for the ﬁrst time, invasively assessed
a typical patient population with symptomatic and advanced HFNEF.
Role of incomplete relaxation
Incomplete relaxation in HFNEF has been evaluated in animal
models
19,20 and also in humans.
5 Zile et al.
5 found incomplete
relaxation to be present in all patients with HFNEF they examined
and we also observed a high prevalence of incomplete relaxation.
Interestingly, despite incomplete relaxation in most patients,
LVEDP decreased with higher pacing rates in HFNEF, a ﬁnding con-
sistent with a recent invasive human study.
4 In contrast, Hay
et al.,
21 using a computer model, assumed that incomplete relax-
ation leads to an increase in LVEDP at higher heart rates. This
difference might be due to changes in parameters not perfectly
resembling the real human situation in this computer-based
model, e.g. end-diastolic volume at 120 b.p.m.
With higher heart rates, our diastole was shortened and incom-
plete relaxation worsened in HFNEF patients. Given the fact that
other indices of diastolic function did not alter or changed only
marginally, we conclude that pre-existing diastolic dysfunction
together with a more incomplete relaxation at higher heart rates
may promote heart failure symptoms in HFNEF.
Rate-dependent changes of pump
function
Previous studies analysing left ventricular volumes at increasing
heart rates (similar to the range in our study) showed conﬂicting
results in healths
22–26 with decreases or no change in stolic
volume during pacing. An explanation for these conﬂicting results
might be related to differences in the age of the control patients:
Figure 5 Cardiac index, stroke volume index, and left ventricular end-diastolic volume at comparable baseline heart rate and at pacing rates
of 100 and 120 b.p.m. All data are shown as mean+SEM. Data are shown in red for the HFNEF and in blue for the control patients. Results of
the multiple measurements ANOVA are shown above the horizontal arrow (for the effects of beats per minute and interaction) and on the
right side of the ﬁgure (for comparison between HFNEF and controls).
R. Wachter et al. 3034a signiﬁcant rate-dependent decrease in left ventricular volumes
was observed in studies with younger control subjects (median
age 35,
23 37,
24 50
22 years, respectively), whereas in our (median
age 65 years) and other studies with older controls (51
25 and
60
26 years), only minor changes were observed. Further studies
in HFNEF should incorporate a second independent measure of
stroke volume with pacing (e.g. thermodilution).
The role of heart rate in HFNEF is controversial. Patients with
HFNEF do, to a signiﬁcant portion, have chronotropic incompe-
tence.
27,28 Therefore, pacing may improve exercise intolerance in
HFNEF. In contrast, there is also evidence that a reduction in
heart rate is beneﬁcial.
29 In our study, HFNEF patients were
unable to adequately increase cardiac output at higher heart
rates. This ﬁnding is consistent with a recent echocardiographic
study in patients with diastolic dysfunction.
30 The relevance of
blunting of the heart rate dependent increase in cardiac output
may depend on the severity of the disease: Westermann et al.,
4
who studied a cohort of relatively young patients in Stage I diastolic
dysfunction, did not observe a difference in cardiac output at rest
between control and HFNEF patients, and observed an increase in
cardiac output with pacing in HFNEF, which was smaller than the
increase in the control group. Therefore, one might speculate that
blunting of frequency-depending upregulation of cardiac output in
HFNEF may progress with the severity of the disease.
Recruitment of patients
It has been previously shown that in a carefully selected cohort of
patients with heart failure and normal ejection fraction, objective
evidence of diastolic dysfunction may not always be necessary.
31
However, in the Echo substudy of the CHARM trial in HFNEF,
33% of patients had no evidence of diastolic dysfunction, and mod-
erate or severe diastolic dysfunction was found in only 44% of the
patients.
32 We therefore believe that in clinical trials, objective evi-
dence of diastolic dysfunction, as proposed in a recent consensus
paper,
8 should be obtained.
Limitations
Atrial pacing may not completely mimic the effects of exercise on
heart rate, myocardial function and global haemodynamics since
exercise-dependent heart rate increases may be associated with
alterations in sympathetic drive and peripheral vascular resistance.
For example, in the recent study by Westermann et al.,
4 pacing was
associated with a decline, but handgrip exercise with an increase in
LVEDP. Thus, future invasive studies should focus on cardiac hae-
modynamics with exercise in patients with HFNEF.
The deﬁnition of incomplete relaxation in humans is not well
standardized. We used a method previously described by
others,
5 but this method is still a matter of debate.
Conclusion
Patients with HFNEF have preserved global systolic function and a
preserved frequency-dependent upregulation of contractility, but
impaired diastolic function and an impaired relaxation–frequency
relation. Our data clearly indicate that increased LV stiffness and
impaired relaxation in HFNEF underlie substantial alterations in
global haemodynamics that are further aggravated by tachycardia
and may explain the symptoms of these patients: dyspnoea on
exertion and exercise intolerance.
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